查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1989950

攜帶式超音波診斷設備市場：按技術、便攜性、應用和最終用戶分類－2026-2032年全球市場預測

Handheld Ultrasound Devices Market by Technology, Portability, Application Areas, End-Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，攜帶式超音波診斷設備市場價值將達到 6.4871 億美元，到 2026 年將成長至 6.8641 億美元，到 2032 年將達到 9.8496 億美元，複合年成長率為 6.14%。

主要市場統計數據
基準年 2025 6.4871億美元
預計年份：2026年 6.8641億美元
預測年份 2032 9.8496億美元
複合年成長率 (%) 6.14%

簡要概述攜帶式超音波診斷設備的創新、整合和臨床部署如何重新定義不同醫療保健環境中的即時成像。

攜帶式超音波診斷設備正在重塑臨床診斷，將即時成像功能帶到以往無法進行高階超音波檢查的環境中。換能器小型化、影像處理演算法和無線資料整合技術的快速發展，顯著提升了其在急診、門診和遠端醫療等臨床環境中的效用。隨著臨床醫生越來越依賴小型掃描儀進行分流、手術指導和後續觀察，這項技術正從輔助工具轉變為許多臨床流程中的核心診斷方法。

快速的硬體進步、嵌入式人工智慧和可互通的軟體生態系統如何融合，從而重新定義攜帶式超音波診斷設備的臨床工作流程和經營模式？

攜帶式超音波診斷設備領域正經歷著一場變革，其驅動力包括技術的成熟、臨床工作流程的演進以及以便攜性和數據驅動診斷為核心的新型服務模式。關鍵硬體的改進，例如高密度壓電陣列和先進的波束形成技術，能夠以更低的功耗獲得更清晰的圖像，而嵌入式人工智慧則可輔助圖像解讀並自動執行常規測量。這些特性降低了對操作者專業知識的依賴，並擴大了可有效使用攜帶式設備的臨床醫生範圍。

評估 2025 年美國對手持式超音波設備零件採購、生產經濟性和上市時間徵收關稅的營運、採購和戰略連鎖反應。

美國於2025年宣布的關稅政策對攜帶式超音波診斷設備產業的製造商和供應鏈管理者而言，構成了一項重大的投入成本考量。對某些進口電子元件和成品徵收的關稅附加稅，增加了依賴全球元件採購的企業的生產成本。為此，一些製造商已對其供應商網路進行審查，尋找替代元件，或遷移生產基地以降低額外成本的風險。

一個多方面的細分框架，揭示了技術模式、便攜性選項、臨床應用和最終用戶需求如何影響產品策略和部署路徑。

詳細的市場細分為評估產品定位、臨床適用性和市場進入策略提供了一個實用的架構。基於技術，市場可細分為：提供核心結構成像的2D超音波平台；增強容積評估和手術規劃的3D/四維系統；以及用於量化血管和心臟應用中血流動力學的多普勒技術。每種模式都針對不同的應用場景和臨床醫生的需求。基於便攜性，設備可分為有線型和無線型。有線型設備提供穩定的電源和數據吞吐量，以實現高清成像；無線型設備則優先考慮移動性和與手持顯示器和智慧型手機的連接性，以便快速進行床邊評估。基於應用領域，臨床應用在不同學科之間存在差異，例如：心臟病學領域，波形和多普勒精度至關重要；急診醫學領域，速度和耐力至關重要；婦產科領域，依賴胎兒可視化和生物特徵分析；肌肉骨骼評估領域，強調高解析度淺表成像；肺部評估領域，優先考慮胸膜和間質可視化。泌尿系統工作流程需要對特定器官進行聚焦成像；血管應用則需要雙重功能來影響介入治療決策。基於最終用戶，不同機構的採購趨勢和實施模式存在顯著差異：門診手術中心優先考慮處理能力和報銷機制；診斷成像中心需要更高的影像精度和PACS整合；醫院尋求企業級可靠性和多部門互通性；婦產科診所則注重易用性、安全性和產前護理流程。整合這四個細分維度，相關人員可以根據每個臨床醫生群體和醫療環境的細微需求，量身定做產品藍圖、臨床培訓、定價結構和實證策略。

美洲、歐洲、中東和非洲以及亞太地區的區域法規結構、報銷結構和醫療保健服務模式對部署、採購和擴大策略。

區域趨勢正在以不同的方式影響美洲、歐洲、中東和非洲以及亞太地區的採納軌跡、報銷框架和採購行為。在美洲，報銷獎勵和完善的醫院網路正在推動急診醫學和循環系統醫學領域的快速普及，而私人診所也擴大採用手持設備來縮短診療週期。相較之下，在歐洲、中東和非洲，法規環境的多樣性和報銷方案的差異要求供應商根據每個國家和醫療體系的不同層級來客製化證據包和定價。在中東和非洲的部分地區，手持設備在擴大服務不足地區診斷成像的覆蓋範圍方面發揮戰略性作用，這通常得益於公私合營舉措以及與非政府組織的夥伴關係。

競爭分析表明，臨床檢驗、軟體生態系統和服務導向經營模式如何決定手持式超音波領域的永續差異化。

攜帶式超音波領域的競爭動態呈現出兩難平衡：一方面是老牌醫療設備製造商不斷拓展其緊湊型產品系列，另一方面是敏捷的新興參與企業著重發展軟體、人工智慧和服務模式。大型設備製造商憑藉深厚的臨床檢驗、廣泛的銷售管道和一體化的服務網路來滿足企業級需求，而小型公司則往往憑藉小眾的臨床功能、顛覆性的價格或專為非專業臨床醫生設計的卓越用戶界面展開競爭。醫療設備製造商與軟體或遠端醫療提供者之間的合作在提供涵蓋影像擷取、雲端儲存、人工智慧輔助診斷成像和長期照護工作流程的端到端夥伴關係正變得日益重要。

為醫療產業領導者和供應商提供可操作的策略重點，以加速手持式超音波設備的臨床部署，降低供應鏈風險，並實現軟體主導服務的貨幣化。

產業領導者應採取整合策略，在提升臨床價值的同時降低推廣門檻。首先，應優先進行嚴格的臨床檢驗項目，針對對自身商業性目標至關重要的特定應用領域和最終用戶。針對循環系統、急診醫學和婦產科的實證醫學證據能夠顯著加速採購決策。其次，應投資開發可互通的軟體堆疊和強大的應用程式介面（API），以確保與電子健康記錄和遠端醫療平台無縫整合，並將設備融入臨床醫生現有的工作流程。此外，還應拓展遠距培訓、遠端指導和訂閱式分析等服務，以提高可預測的收入來源和客戶維繫留存率。

採用透明且可重複的混合方法，結合臨床醫生訪談、監管和技術審查以及情境分析，以檢驗對手持超音波的見解。

本研究採用系統性的調查方法，結合與關鍵相關人員的對話、對二手文獻的回顧以及技術比較評估。主要資訊來源包括對急診醫學、循環系統、婦產科和門診臨床醫生、多院區醫院系統的採購負責人以及負責設備部署的產品經理的詳細訪談。這些訪談旨在揭示真實的臨床應用案例、訓練缺口、採購標準以及預期的部署障礙。二級資訊來源，包括同行評審的臨床研究、監管核准、設備技術規格以及公開的政策文件，用於全面檢驗研究結果並確保事實準確性。

簡要概述了檢驗的臨床結果、可互通的平台和供應鏈彈性為何是主導不斷發展的攜帶式超音波診斷設備市場的關鍵因素。

攜帶式超音波診斷設備正從輔助設備轉變為主流診斷工具，並在不斷擴展的臨床環境中得到應用。成像硬體、人工智慧影像分析和無線連接等方面的技術進步降低了使用門檻，從而加快了床邊決策速度，並促進了分散式診療路徑的建構。貿易和供應鏈趨勢，包括關稅帶來的成本壓力，正促使人們重新評估籌資策略，並加速對能夠降低硬體利潤率依賴的軟體和服務的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：攜帶式超音波診斷設備市場：依技術分類

  • 2D超音波
  • 3D/4D超音波
  • 多普勒超音波

第9章攜帶式超音波診斷設備市場便攜性

  • 有線
  • 無線的

第10章：攜帶式超音波診斷設備市場（按應用領域分類）

  • 循環系統
  • 緊急醫療護理
  • 婦科和產科
  • 肌肉骨骼系統
  • 呼吸系統
  • 泌尿系統
  • 血管

第11章：攜帶式超音波診斷設備市場：按最終用戶分類

  • 門診手術中心
  • 診斷影像中心
  • 醫院
  • 婦產科診所

第12章：攜帶式超音波診斷設備市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：攜帶式超音波診斷設備市場：按類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：攜帶式超音波診斷設備市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國攜帶式超音波診斷設備市場

第16章：中國攜帶式超音波診斷設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aco Healthcare Co., Ltd.
  • ASUSTeK Computer Inc.
  • Bmv AG
  • Butterfly Network Inc.
  • CANON MEDICAL SYSTEMS CORPORATION
  • CHISON Medical Technologies Co., Ltd.
  • Clarius Mobile Health Corp.
  • Dawei Group
  • DGH Technology, Inc.
  • Draminski SA
  • EchoNous Inc.
  • Esaote SPA
  • FUJIFILM Sonosite, Inc.
  • General Electric Company
  • Guangdong Youkey Medical Co., Ltd.
  • Healcerion Co., Ltd.
  • Interson Corporation
  • Konica Minolta, Inc.
  • Koninklijke Philips NV
  • Leltek Inc.
  • Promed Technology Co., Limited
  • Samsung Electronics Co., Ltd
  • SHENNONA Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Siemens Healthineers AG
  • SIFSOF LLC
  • Sonoscanner SARL
  • Sonostar Technologies Co., Limited
  • Swissray International, Inc
  • Telemed Medical Systems Srl
  • Terason by Teratech Corporation
  • VINNO Corporation
  • Xuzhou Ruisheng Chaoying Electronic Technology Co., Ltd.
Product Code: MRR-CD5A9334D0BD

The Handheld Ultrasound Devices Market was valued at USD 648.71 million in 2025 and is projected to grow to USD 686.41 million in 2026, with a CAGR of 6.14%, reaching USD 984.96 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 648.71 million
Estimated Year [2026] USD 686.41 million
Forecast Year [2032] USD 984.96 million
CAGR (%) 6.14%

A concise overview of how handheld ultrasound innovation, integration, and clinical adoption are redefining point-of-care imaging across diverse care environments

Handheld ultrasound devices are reshaping point-of-care diagnostics by bringing real-time imaging capability to environments that traditionally lacked advanced sonography. Rapid advances in transducer miniaturization, image-processing algorithms, and wireless data integration have elevated clinical utility across emergency, ambulatory, and remote care settings. As clinicians increasingly rely on compact scanners for triage, procedural guidance, and longitudinal monitoring, the technology is shifting from a supplemental tool to a core diagnostic modality in many care pathways.

This evolution is driven by converging forces: improved image clarity that rivals conventional cart-based systems for certain applications, declining hardware cost enabled by semiconductor innovation, and greater interoperability with electronic health records and telemedicine platforms. Consequently, healthcare teams can accelerate clinical decisions, reduce patient transfers, and expand access to diagnostic imaging in resource-limited contexts. These dynamics demand that technology purchasers, clinical leaders, and policy makers reassess procurement criteria, training frameworks, and care protocols to fully realize the value proposition of handheld ultrasound solutions.

In what follows, the executive summary synthesizes major shifts, regulatory and trade headwinds, segmentation insights, regional considerations, competitive dynamics, and pragmatic recommendations for leaders seeking to incorporate handheld ultrasound into clinical and commercial strategies.

How rapid hardware advancements, embedded AI, and interoperable software ecosystems are converging to redefine clinical workflows and commercial models in handheld ultrasound

The handheld ultrasound landscape is undergoing transformative shifts driven by technological maturation, evolving clinical workflows, and new service models that prioritize portability and data-driven diagnostics. Key hardware improvements such as higher-density piezoelectric arrays and advanced beamforming enable clearer images with lower power consumption, while embedded AI assists interpretation and automates routine measurements. These capabilities reduce dependence on operator expertise, thereby broadening the pool of clinicians who can effectively use handheld devices.

Concurrently, software ecosystems are converging on interoperable standards, making it easier to integrate handheld devices with electronic health records, telemedicine platforms, and cloud-based analytics. This convergence supports new care models, such as remote consultations and community-based screening programs, that rely on rapid image sharing and asynchronous expert review. Payment models are adapting as well, with some payers recognizing the cost-offsets from reduced imaging center referrals and shorter hospital stays.

As adoption accelerates, the competitive landscape is also shifting toward ecosystem playbooks where device vendors partner with software providers and clinical networks to deliver bundled solutions. These collaborative arrangements create higher switching costs for customers but also increase overall value by ensuring continuous software updates, training, and service support. Taken together, these trends point to a future where handheld ultrasound becomes an embedded capability across many front-line care settings rather than a niche diagnostic adjunct.

Assessing the cascading operational, procurement, and strategic effects of the 2025 United States tariffs on component sourcing, production economics, and launch timing in handheld ultrasound

United States tariffs announced in 2025 have introduced a notable input cost consideration for manufacturers and supply chain managers in the handheld ultrasound space. Tariff-related duties on certain imported electronic components and finished devices increased production cost layers for firms reliant on globalized component sourcing. In response, some manufacturers reassessed their supplier networks, pursued alternate component substitutes, or reallocated production to mitigate incremental cost exposure.

These adjustments have produced uneven impacts across the value chain. Original equipment manufacturers with vertically integrated component sourcing or domestic assembly windows were better positioned to absorb or offset tariff-driven cost increases. Conversely, smaller innovators and contract manufacturers that depend on specialized foreign suppliers encountered tighter margin pressure and in some cases deferred commercial rollouts. Importantly, regulatory approvals and clinical validation timelines remained unchanged, but pricing strategies and commercial launch sequencing were recalibrated to reflect revised cost bases.

Looking forward, many stakeholders are exploring strategic hedges such as diversifying supplier footprints, negotiating long-term component contracts, and increasing emphasis on software and service revenue streams that are less sensitive to hardware import costs. These moves underscore a broader industry shift toward resilient supply chains and a heightened focus on total cost of ownership when evaluating procurement and deployment of handheld ultrasound solutions.

A multidimensional segmentation framework illuminating how technology modalities, portability choices, clinical applications, and end-user needs drive product strategy and adoption pathways

Detailed segmentation provides a pragmatic framework for evaluating product positioning, clinical suitability, and go-to-market tactics. Based on technology, the landscape differentiates 2D ultrasound platforms that deliver core structural imaging, 3D/4D systems that enhance volumetric assessment and procedural planning, and Doppler technologies that quantify flow dynamics for vascular and cardiac applications; each modality targets distinct diagnostic use cases and clinician requirements. Based on portability, devices fall into wired forms that deliver consistent power and data throughput for high-fidelity imaging, and wireless variants that prioritize mobility and integration with handheld displays and smartphones for rapid bedside assessments. Based on application areas, clinical adoption diverges across cardiology where waveform and Doppler accuracy are critical, emergency medicine where speed and durability matter most, gynecological and obstetrics services that rely on fetal visualization and biometric analytics, musculoskeletal evaluations that emphasize high-resolution superficial imaging, pulmonary assessments that prioritize pleural and interstitial visualization, urological workflows that require focused organ imaging, and vascular applications where duplex capability can influence interventional decisions. Based on end-users, purchasing dynamics and deployment models vary substantially across ambulatory surgical centers that emphasize throughput and reimbursement alignment, diagnostic imaging centers that require higher imaging fidelity and integration with PACS, hospitals that demand enterprise-grade reliability and multi-departmental interoperability, and maternity clinics that focus on ease of use, safety, and prenatal care pathways. Integrating these four segmentation axes enables stakeholders to align product roadmaps, clinical training, pricing structures, and evidence generation strategies with the nuanced needs of each clinician cohort and care environment.

How regional regulatory frameworks, reimbursement structures, and care delivery models across the Americas, Europe Middle East & Africa, and Asia-Pacific influence adoption, procurement, and scaling strategies

Regional dynamics shape adoption trajectories, reimbursement frameworks, and procurement behaviors in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, reimbursement incentives and strong hospital networks drive rapid adoption in both emergency medicine and cardiology, while private clinics increasingly deploy handheld units to shorten care cycles. Conversely, in Europe, Middle East & Africa, heterogeneous regulatory environments and variable reimbursement schemes require vendors to tailor evidence packages and price positioning by country and health system tier. In parts of the Middle East and Africa, handheld devices play a strategic role in expanding access to imaging in underserved regions, often supported by public-private initiatives and NGO partnerships.

In the Asia-Pacific region, high-volume ambulatory settings and large community health networks accelerate uptake of wireless and AI-enabled devices that can scale across diverse care sites. Moreover, supply chain proximity to component manufacturers in several Asia-Pacific markets enables faster product iteration and cost optimization for regional producers. Across all regions, interoperability expectations, data privacy regulations, and clinician training infrastructures shape deployment speed and long-term utilization. Consequently, vendors and health system leaders must craft region-specific strategies that reflect regulatory realities, reimbursement mechanics, and the local balance between centralized imaging facilities and decentralized point-of-care services.

An analysis of competitive dynamics showing how clinical validation, software ecosystems, and service-oriented business models determine sustainable differentiation in handheld ultrasound

Competitive dynamics in the handheld ultrasound segment reflect a balance between established medical device firms expanding compact portfolios and agile entrants emphasizing software, AI, and service models. Leading device creators leverage deep clinical validation, broad sales channels, and integrated service networks to meet enterprise requirements, while smaller companies often compete on niche clinical features, disruptive pricing, or superior user interfaces designed for non-specialist clinicians. Partnerships between device manufacturers and software or telehealth providers are increasingly central to delivering end-to-end solutions that encompass image acquisition, cloud storage, AI-assisted interpretation, and longitudinal care workflows.

Additionally, as procurement committees prioritize total cost of ownership and lifecycle services, after-sales support, training programs, and remote update capabilities have become key differentiators. Investment patterns reflect these priorities, with venture and strategic capital favoring firms that can demonstrate recurrent revenue through subscription models, analytics services, or enterprise licensing. Regulatory approvals and clinical evidence remain critical gatekeepers, particularly for cardiology and obstetrical applications where diagnostic accuracy directly affects care decisions. Overall, competitors that combine robust clinical validation with scalable software and service offerings are best positioned to capture sustained enterprise demand.

Actionable strategic priorities for healthcare leaders and vendors to accelerate clinical adoption, de-risk supply chains, and monetize software-driven services in handheld ultrasound

Industry leaders should pursue integrated strategies that amplify clinical value while reducing adoption friction. First, prioritize rigorous clinical validation programs targeted to the specific application areas and end-users most critical to your commercial objectives; evidence aligned to cardiology, emergency medicine, or obstetrics can materially accelerate procurement decisions. Next, invest in interoperable software stacks and robust APIs to ensure seamless integration with electronic health records and telehealth platforms, thereby embedding devices into clinicians' existing workflows. In addition, expand service offerings such as remote training, tele-mentoring, and subscription-based analytics to create predictable revenue streams and higher customer retention.

From an operational perspective, diversify component sourcing and explore localized assembly or certification pathways to mitigate trade-related cost volatility. Align pricing and procurement models with customer pain points by offering bundled hardware-plus-software packages and flexible licensing that reflect use intensity. Finally, cultivate partnerships with clinical societies, teaching hospitals, and payers to develop adoption incentives and guidelines that support broader clinical acceptance. By combining targeted evidence generation, software-led integration, resilient supply chain design, and value-based commercial models, leaders can accelerate adoption and capture sustained clinical and economic benefit.

A transparent and reproducible mixed-methods approach blending clinician interviews, regulatory and technical review, and scenario analysis to validate handheld ultrasound insights

This research synthesis integrates a structured methodology combining primary stakeholder engagement, secondary literature review, and comparative technology assessment. Primary inputs included in-depth interviews with clinicians across emergency, cardiology, obstetrics, and outpatient care settings, procurement officers from multi-site hospital systems, and product leaders responsible for device deployment. These interviews were designed to surface real-world use cases, training gaps, procurement criteria, and anticipated adoption barriers. Secondary sources encompassed peer-reviewed clinical studies, regulatory approvals, device technical specifications, and publicly available policy documents to triangulate findings and ensure factual accuracy.

Analytical approaches employed include comparative capability mapping across device modalities, scenario analysis to assess procurement and deployment pathways, and supply chain vulnerability assessment to understand exposure to tariff and component risk. Cross-validation between primary and secondary inputs ensured consistency and reduced single-source bias. Limitations are acknowledged where clinical practices vary by region and where longitudinal real-world evidence is still emerging for certain AI-enabled features. Nevertheless, the methodology emphasizes reproducibility and transparency to support confident decision-making by clinical, technical, and commercial stakeholders.

A concise synthesis highlighting why validated clinical outcomes, interoperable platforms, and supply chain resilience will determine leadership in the evolving handheld ultrasound landscape

Handheld ultrasound devices are transitioning from niche adjuncts to mainstream diagnostic tools across an expanding set of clinical contexts. Technological advances in imaging hardware, AI-driven interpretation, and wireless connectivity have reduced barriers to use, enabling faster bedside decisions and more decentralized care pathways. Trade and supply chain dynamics, including tariff-induced cost pressures, have prompted a re-evaluation of sourcing strategies and accelerated interest in software and services that dilute hardware margin sensitivity.

Adoption will continue to be shaped by targeted clinical evidence, reimbursement alignment, and the degree to which devices seamlessly integrate into existing workflows. Regional differences in procurement norms and regulatory expectations require tailored commercial approaches, and competitive advantage increasingly accrues to organizations that deliver validated clinical outcomes coupled with robust software ecosystems and sustainable service models. In sum, stakeholders that combine rigorous clinical validation, interoperable platforms, and resilient supply chains will be best positioned to lead the next wave of handheld ultrasound adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Handheld Ultrasound Devices Market, by Technology

  • 8.1. 2D Ultrasound
  • 8.2. 3D/4D Ultrasound
  • 8.3. Doppler Ultrasound

9. Handheld Ultrasound Devices Market, by Portability

  • 9.1. Wired
  • 9.2. Wireless

10. Handheld Ultrasound Devices Market, by Application Areas

  • 10.1. Cardiology
  • 10.2. Emergency Medicine
  • 10.3. Gynecological/Obstetrics
  • 10.4. Musculoskeletal
  • 10.5. Pulmonary
  • 10.6. Urological
  • 10.7. Vascular

11. Handheld Ultrasound Devices Market, by End-Users

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals
  • 11.4. Maternity Clinics

12. Handheld Ultrasound Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Handheld Ultrasound Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Handheld Ultrasound Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Handheld Ultrasound Devices Market

16. China Handheld Ultrasound Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aco Healthcare Co., Ltd.
  • 17.6. ASUSTeK Computer Inc.
  • 17.7. Bmv AG
  • 17.8. Butterfly Network Inc.
  • 17.9. CANON MEDICAL SYSTEMS CORPORATION
  • 17.10. CHISON Medical Technologies Co., Ltd.
  • 17.11. Clarius Mobile Health Corp.
  • 17.12. Dawei Group
  • 17.13. DGH Technology, Inc.
  • 17.14. Draminski SA
  • 17.15. EchoNous Inc.
  • 17.16. Esaote SPA
  • 17.17. FUJIFILM Sonosite, Inc.
  • 17.18. General Electric Company
  • 17.19. Guangdong Youkey Medical Co., Ltd.
  • 17.20. Healcerion Co., Ltd.
  • 17.21. Interson Corporation
  • 17.22. Konica Minolta, Inc.
  • 17.23. Koninklijke Philips N.V.
  • 17.24. Leltek Inc.
  • 17.25. Promed Technology Co., Limited
  • 17.26. Samsung Electronics Co., Ltd
  • 17.27. SHENNONA Co., Ltd.
  • 17.28. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • 17.29. Siemens Healthineers AG
  • 17.30. SIFSOF LLC
  • 17.31. Sonoscanner SARL
  • 17.32. Sonostar Technologies Co., Limited
  • 17.33. Swissray International, Inc
  • 17.34. Telemed Medical Systems Srl
  • 17.35. Terason by Teratech Corporation
  • 17.36. VINNO Corporation
  • 17.37. Xuzhou Ruisheng Chaoying Electronic Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HANDHELD ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HANDHELD ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY 2D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY 2D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY 2D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY 3D/4D ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY 3D/4D ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY 3D/4D ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY DOPPLER ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY DOPPLER ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY DOPPLER ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY WIRED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY WIRED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY WIRED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY WIRELESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY WIRELESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY WIRELESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY EMERGENCY MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY EMERGENCY MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY EMERGENCY MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY GYNECOLOGICAL/OBSTETRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY GYNECOLOGICAL/OBSTETRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY GYNECOLOGICAL/OBSTETRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY MUSCULOSKELETAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY MUSCULOSKELETAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PULMONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PULMONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PULMONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY MATERNITY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY MATERNITY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY MATERNITY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 101. GCC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GCC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 104. GCC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 105. GCC HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPEAN UNION HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPEAN UNION HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 111. BRICS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. BRICS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. BRICS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 116. G7 HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. G7 HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. G7 HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 119. G7 HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 120. G7 HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 121. NATO HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. NATO HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. NATO HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 124. NATO HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 125. NATO HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. UNITED STATES HANDHELD ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. UNITED STATES HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. UNITED STATES HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 130. UNITED STATES HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 131. UNITED STATES HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)
  • TABLE 132. CHINA HANDHELD ULTRASOUND DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. CHINA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. CHINA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 135. CHINA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 136. CHINA HANDHELD ULTRASOUND DEVICES MARKET SIZE, BY END-USERS, 2018-2032 (USD MILLION)